0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Quantitative FDG PET/CT may help risk-stratify early-stage non-small cell lung cancer patients at risk for recurrence following anatomic resection

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Preoperative identification of non-small cell lung cancer (NSCLC) patients at risk for disease recurrence has proven unreliable. The extraction of quantitative metrics from imaging based on tumor intensity and texture may enhanced disease characterization. This study evaluated tumor-specific 18F-fluorodeoxyglucose ( 18F-FDG) positron emission tomography/computerized tomography (PET/CT) uptake patterns and their association with disease recurrence in early-stage NSCLC.

          Methods

          Sixty-four stage I/II NSCLC patients who underwent anatomic resection between 2001 and 2014 were examined. Pathologically or radiographic confirmed disease recurrence within 5 years of resection comprised the study group. Quantitative imaging metrics were extracted within the primary tumor volume. Squamous cell carcinoma (SCC) (N=27) and adenocarcinoma (AC) (N=41) patients were compared using a Wilcoxon signed-rank test. Associations between imaging and clinical variables with 5-year disease-free survival (DFS) and overall survival (OS) were evaluated by Cox proportional-hazards regression.

          Results

          Clinical and pathologic characteristics were similar between recurrence (N=34) and patients achieving 5-year DFS (N=30). Standardized uptake value (SUV) max and SUV mean varied significantly by histology, with SCC demonstrating higher uptake intensity and heterogeneity patterns. Entropy-grey-level co-occurrence matrix (GLCM) was a significant univariate predictor of DFS (HR =0.72, P=0.04) and OS (HR =0.65, P=0.007) independent of histology. Texture features showed higher predictive ability for DFS in SCC than AC. Pathologic node status and staging classification were the strongest clinical predictors of DFS, independent of histology.

          Conclusions

          Several imaging metrics correlate with increased risk for disease recurrence in early-stage NSCLC. The predictive ability of imaging was strongest when patients are stratified by histology. The incorporation of 18F-FDG PET/CT texture features with preoperative risk factors and tumor characteristics may improve identification of high-risk patients.

          Related collections

          Author and article information

          Journal
          J Thorac Dis
          J Thorac Dis
          JTD
          Journal of Thoracic Disease
          AME Publishing Company
          2072-1439
          2077-6624
          April 2019
          April 2019
          : 11
          : 4
          : 1106-1116
          Affiliations
          [1 ]Department of Medical Physics, University of Wisconsin , Madison, WI, USA;
          [2 ]Department of Thoracic and Cardiovascular Surgery, Rush University Medical Center , Chicago, IL, USA;
          [3 ]Department of Nuclear Medicine, The 1st Hospital of China Medical University , Shenyang 110016, China;
          [4 ]Department of Surgery, Yale University , New Haven, CT, USA
          Author notes

          Contributions: (I) Conception and design: All authors; (II) Administrative support: R Jeraj; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: S Harmon, R Jeraj, JD Blasberg; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

          Correspondence to: Justin D. Blasberg, MD. 330 Cedar Street, BB 205, New Haven, CT 06510, USA. Email: justin.blasberg@ 123456yale.edu .
          Article
          PMC6531752 PMC6531752 6531752 jtd-11-04-1106
          10.21037/jtd.2019.04.46
          6531752
          31179052
          6e228e6e-4582-4bd8-930d-ce34c9a089d6
          2019 Journal of Thoracic Disease. All rights reserved.
          History
          : 14 January 2019
          : 03 April 2019
          Categories
          Original Article

          clinical outcome,surgical resection,early-stage non-small cell lung cancer (early-stage NSCLC),quantitative imaging,Positron emission tomography (PET)

          Comments

          Comment on this article